Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry

Major depressive disorder (MDD) is a neuropsychiatric illness with an increasing incidence and a shortfall of efficient diagnostic tools. Interview-based diagnostic tools and clinical examination often lead to misdiagnosis and inefficient systematic treatment selection. Diagnostic and treatment moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Homorogan, Claudia, Nitusca, Diana, Enatescu, Virgil, Schubart, Philip, Moraru, Corina, Socaciu, Carmen, Marian, Catalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306682/
https://www.ncbi.nlm.nih.gov/pubmed/34357360
http://dx.doi.org/10.3390/metabo11070466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306682/
https://www.ncbi.nlm.nih.gov/pubmed/34357360
http://dx.doi.org/10.3390/metabo11070466

Ejemplares similares